Chemedsyn Life Sciences Private Limited
Founded in 2018 and headquartered in Telangana, India.
2018 | Hyderabad, Telangana (India) | Active
Chemedsyn Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -24.03%
- Profit Growth 11.86%
- Ebitda -1.30%
- Net Worth 5.32%
- Total Assets 28.27%
About Chemedsyn Life Sciences
Chemedsyn Life Sciences Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2018 (Seven years 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Markandeya Nagula and Ravi Vemula serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304TG2018PTC122220
- Company No.
122220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Food And Beverages
Textile
Who are the key members and board of directors at Chemedsyn Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Markandeya Nagula  | Director | 12-Feb-2018 | Current |
| Ravi Vemula | Director | 12-Feb-2018 | Current |
Financial Performance of Chemedsyn Life Sciences.
Chemedsyn Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.03% decrease. The company also saw a substantial improvement in profitability, with a 11.86% increase in profit. The company's net worth moved up by a moderate rise of 5.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemedsyn Life Sciences?
Unlock access to Chemedsyn Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemedsyn Life Sciences?
Unlock and access historical data on people associated with Chemedsyn Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemedsyn Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemedsyn Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.